Digitalis receptors and digoxin sensitivity in renal failure

Area of Science:

• Pharmacology
• Nephrology
• Cardiology

Background:

• Cardiac glycosides, like digoxin, are crucial for managing heart failure.
• Chronic renal failure (CRF) can alter drug efficacy, including cardiac glycosides.
• Digitalis receptor availability and affinity are key determinants of digoxin's action.

Purpose of the Study:

• To investigate the impact of uraemia on digitalis receptor characteristics.
• To explore the pharmacodynamic basis for altered cardiac glycoside activity in CRF.
• To compare digoxin receptor parameters in patients with normal renal function versus uraemic patients.

Main Methods:

• Measurement of digitalis receptor number and affinity (in vitro and in vivo) for digoxin.
• Comparison between patients with normal renal function and uraemic patients.
• Assessment of potential influence of hyperkalaemia on in vivo affinity.

Main Results:

• Uraemic patients exhibited a decreased number of digitalis receptors.
• In vitro affinity of digitalis receptors for digoxin remained unchanged in uraemia.
• In vivo affinity for digoxin was decreased in uraemic patients, potentially due to hyperkalaemia.

Conclusions:

• Reduced digitalis receptor number and in vivo affinity in uraemia contribute to decreased cardiac glycoside activity.
• Hyperkalaemia is a likely factor in the diminished in vivo affinity observed in uraemic patients.
• These findings offer a pharmacodynamic explanation for the reduced efficacy of cardiac glycosides in chronic renal failure.